Adipocyte-mediated inflammatory signaling has been proposed to alter adipose physiology in obesity. Activation of adipocytes can increase secretion of inflammatory cytokines such as IL-6. IL-6 secretion is regulated through changes in expression of both IL-6 itself, as well as its specific SNARE trafficking machinery. Recent data suggests that the γ-secretase enzyme complex is involved in both adipose insulin sensitivity and immune system regulation. We therefore hypothesized that adipocyte IL-6 secretion could be altered by γ-secretase inhibition. To explore this hypothesis, 3T3-L1 adipocytes were stimulated with lipopolysaccharide (LPS) in the absence or presence of a γ-secretase inhibitor. Changes in gene expression of inflammatory cytokines and SNARE complex components, including IL-6, MCP1, Stx6, Vti1b, SCAMP5, VAMP3, Stx4, and SNAP23 were examined by qRT-PCR, and immunofluorescence (IF) was used to determine adipocyte IL-6 expression and localization. IL-6 secretion was analyzed by ELISA. Transcription of IL-6 and several of the SNARE complex proteins were not significantly affected by γ-secretase inhibition. However, total cellular IL-6 increased by LPS stimulation by IF, which could be blocked by pre-treatment with a γ-secretase inhibitor. IL-6-associated SNARE component Vti1b mRNA levels were specifically affected by overnight γ-secretase inhibition. LPS stimulation increased Vti1b transcription 3-fold, which was completely blocked by γ-secretase inhibition (p<0.01, n=6 per condition). Increasing amounts of LPS (range 0 to 10 ng/mL) for 6 hours led to an expected increase in IL-6 secretion, which was significantly blocked by overnight pre-treatment with a γ-secretase inhibitor. LPS-stimulated IL-6 secretion could also be decreased by short-term (30 minute) γ-secretase blockade. Taken together, this data suggests that the γ-secretase enzyme complex may be involved in a variety of signaling cascades controlling both the production and secretion of IL-6 in adipocytes.

Disclosure

D. Sparling: None. N. McCullough: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.